Dr. Wasik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
333 Cottman Avenue
Philadelphia, PA 19111Phone+1 215-662-6503- Is this information wrong?
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematopathology, 1992 - 1993
- Boston University Medical CenterResidency, Pathology-Anatomic and Clinical, 1988 - 1991
- Wroclaw Medical UniversityClass of 1979
Certifications & Licensure
- PA State Medical License 1993 - 2024
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- Genomic Evolution of Oligometastatic Clear Cell Renal Cell Carcinoma Presenting Two Decades Following Radical Nephrectomy.Uzzo, N., Pei, J., Baldwin, D., Wang, R., Chelluri, R., Mackrides, N., Ehya, H., Wasik, M., Wei, S., Uzzo, R.> ;Urology. 2024 Feb 1
- Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL).Pin Lu, Devang Thakkar, Vanessa Dupoux, Shazia Nakhoda, Don A Baldwin, Jianming Pei, Sandeep S Dave, Y Lynn Wang, Wasik, M., Kim, P., Nejati, R., Mackrides, N.> ;Cold Spring Harbor Molecular Case Studies. 2023 Dec 1
- Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing.Sandra V Fernandez, Yin Fei Tan, Shilpa Rao, Patricia Fittipaldi, Fathima Sheriff, Hossein Borghaei, Efrat Dotan, Jennifer S Winn, Martin J Edelman, Joseph Treat, Juli...> ;International Journal of Molecular Sciences. 2023 Oct 30
- Join now to see all
Journal Articles
- LRPAP1 Is a Frequent Proliferation-Inducing Antigen of BCRs of Mantle Cell Lymphomas and Can Be Used for Specific Therapeutic TargetingStephen J Schuster, Mariusz Wasik, Nature
Press Mentions
- Mariusz Wasik Joins Fox Chase Cancer Center as Chair of PathologyMay 23rd, 2018
Grant Support
- Novel Role Of STAT3 In Npm/Alk-Induced OncogenesisNational Cancer Institute2009–2012
- JAK/STAT Signaling In Human T-Cell LymphomasNational Cancer Institute2006–2010
- (M) TOR Signaling In Ebv-Associated LymphomasNational Institute Of Dental &Craniofacial Research2005–2007
- Dysregulation Of STAT3 In Alk-Induced OncogenesisNational Cancer Institute2002–2006
- Aberrant JAK/STAT Signaling In Cutaneous T Cell LymphomaNational Cancer Institute2001–2005
- IL 2R Signaling Pathways In T Cell LymphomaNational Cancer Institute1999
Hospital Affiliations
- Fox Chase Cancer CenterPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: